Cargando…

A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns

Very long-chain acylcarnitine dehydrogenase deficiency (VLCADD) is a rare inherited metabolic disorder associated with fatty acid β-oxidation and characterized by genetic mutations in the ACADVL gene and accumulations of acylcarnitines. VLCADD, developed in neonates or later adults, can be diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sebaa, Rajaa, AlMalki, Reem H., Alseraty, Wafaa, Abdel Rahman, Anas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301765/ https://www.ncbi.nlm.nih.gov/pubmed/37367883 http://dx.doi.org/10.3390/metabo13060725

Ejemplares similares

Untargeted Metabolomics Identifies Biomarkers for MCADD Neonates in Dried Blood Spots
por: Sebaa, Rajaa, et al.
Publicado: (2023)

Pervasive inflammatory activation in patients with deficiency in very‐long‐chain acyl‐coA dehydrogenase (VLCADD)
por: Vallejo, Abbe N, et al.
Publicado: (2021)

E. coli Secretome Metabolically Modulates MDA-MB-231 Breast Cancer Cells’ Energy Metabolism
por: AlMalki, Reem H., et al.
Publicado: (2023)

The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment
por: Jaber, Malak A., et al.
Publicado: (2022)

Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity
por: Hagemeijer, Marne C., et al.
Publicado: (2021)

Acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency in newborns
por: Tan, Yifei, et al.
Publicado: (2023)

Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
por: Al-Ansari, Mysoon M., et al.
Publicado: (2021)

Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
por: Alodaib, Ahmad N., et al.
Publicado: (2023)

Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity
por: Shi, Congcong, et al.
Publicado: (2023)

The significance of acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency
por: Shi, Congcong, et al.
Publicado: (2023)

Diagnosis of LCHAD/TFP deficiency in an at risk newborn using umbilical cord blood acylcarnitine analysis
por: Raval, Donna B., et al.
Publicado: (2016)

Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening
por: Cicalini, Ilaria, et al.
Publicado: (2021)

Similarities between acylcarnitine profiles in large for gestational age newborns and obesity
por: Sánchez-Pintos, Paula, et al.
Publicado: (2017)

New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
por: Baydakova, Galina V., et al.
Publicado: (2023)

Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China
por: Zhou, Duo, et al.
Publicado: (2022)

Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
por: Nowak, Christoph, et al.
Publicado: (2018)

Targeted metabolomics for serum amino acids and acylcarnitines in patients with lung cancer
por: Ni, Junjun, et al.
Publicado: (2019)

Metabolomic profile of patients on levothyroxine treatment for hypothyroidism
por: Benabdelkamel, Hicham, et al.
Publicado: (2023)

Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues
por: Makrecka-Kuka, Marina, et al.
Publicado: (2017)

First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach
por: Koster, Maria P. H., et al.
Publicado: (2015)

Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related Intoxication
por: Elmsjö, Albert, et al.
Publicado: (2022)

Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer
por: Li, Dehong, et al.
Publicado: (2022)

Association of plasma acylcarnitines and amino acids with hypertension: A nationwide metabolomics study
por: Arjmand, Babak, et al.
Publicado: (2023)

Newborn Screening for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase and Mitochondrial Trifunctional Protein Deficiencies Using Acylcarnitines Measurement in Dried Blood Spots—A Systematic Review of Test Accuracy
por: Stinton, Chris, et al.
Publicado: (2021)

A newborn case with carnitine palmitoyltransferase II deficiency initially judged as unaffected by acylcarnitine analysis soon after birth
por: Yamada, Kenji, et al.
Publicado: (2017)

Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency
por: Brown, Madalyn, et al.
Publicado: (2020)

Lipids Alterations Associated with Metformin in Healthy Subjects: An Investigation Using Mass Spectrometry Shotgun Approach
por: Dahabiyeh, Lina A., et al.
Publicado: (2022)

NMR Characterization of Long-Chain Fatty Acylcarnitine Binding to the Mitochondrial Carnitine/Acylcarnitine Carrier
por: Zhang, Ningning, et al.
Publicado: (2022)

A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients
por: Aleidi, Shereen M., et al.
Publicado: (2021)

Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program
por: Remec, Ziga I., et al.
Publicado: (2021)

Enhanced Acylcarnitine Annotation in High-Resolution Mass Spectrometry Data: Fragmentation Analysis for the Classification and Annotation of Acylcarnitines
por: van der Hooft, Justin J. J., et al.
Publicado: (2015)

Ramipril Reduces Acylcarnitines and Distinctly Increases Angiotensin-Converting Enzyme 2 Expression in Lungs of Rats
por: Kosacka, Joanna, et al.
Publicado: (2022)

Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia
por: Céspedes, Nora, et al.
Publicado: (2017)

Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle
por: Michel, Miriam, et al.
Publicado: (2020)

Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022)

Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus
por: Gu, Xinyun, et al.
Publicado: (2020)

Acylcarnitines: Reflecting or Inflicting Insulin Resistance?
por: Schooneman, Marieke G., et al.
Publicado: (2013)

Plasma acylcarnitines are associated with pulmonary hypertension
por: Luo, Nancy, et al.
Publicado: (2017)

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
por: Mu, Xiaodie, et al.
Publicado: (2022)

Acylcarnitines in Ophthalmology: Promising Emerging Biomarkers
por: Theodoridis, Konstantinos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_24kutamajdbaa9qcjrv50nehaa